Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion type Assertion NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_head.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion description "[The CD34+ restricted pattern of expression of CML28 and CML66 is particularly relevant in light of the notion that DLI likely exerts its curative effect by targeting antigens present in self-renewing malignant progenitor populations in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_provenance.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion evidence source_evidence_literature NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_provenance.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion SIO_000772 15958636 NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_provenance.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion wasDerivedFrom befree-2016 NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_provenance.
- NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_assertion wasGeneratedBy ECO_0000203 NP499795.RAfsBcIv3FDNjdP0X96TeNIxIUBJqws_eetKL6gmYo6is130_provenance.